1. Home
  2. QRHC vs RNAZ Comparison

QRHC vs RNAZ Comparison

Compare QRHC & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Resource Holding Corporation

QRHC

Quest Resource Holding Corporation

HOLD

Current Price

$1.17

Market Cap

28.9M

Sector

Utilities

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$1.80

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QRHC
RNAZ
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9M
27.9M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
QRHC
RNAZ
Price
$1.17
$1.80
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $3.25
N/A
AVG Volume (30 Days)
19.5K
★ 50.3K
Earning Date
11-09-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $138,346,327.00
N/A
Revenue This Year
$2.71
N/A
Revenue Next Year
$5.76
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.81
$1.52
52 Week High
$2.41
$15.33

Technical Indicators

Market Signals
Indicator
QRHC
RNAZ
Relative Strength Index (RSI) 27.99 47.44
Support Level $1.03 $1.83
Resistance Level $1.17 $1.93
Average True Range (ATR) 0.07 0.16
MACD -0.02 0.08
Stochastic Oscillator 24.72 79.27

Price Performance

Historical Comparison
QRHC
RNAZ

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: